Point72 Asset Management’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Point72 Asset Management’s Portfolio VCNX Stock Details VCNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-166,000	Closed	-$564K	–	2564
2024 Q3	$564K	Buy	166,000 +49,454	+42%	+$278K	﹤0.01%	1583
2024 Q2	$756K	Hold	116,546	–	–	﹤0.01%	1343
2024 Q1	$864K	Buy	+116,546	New	+$1.01M	﹤0.01%	1496
2022 Q2	–	Sell	-1,079	Closed	-$299K	–	1698
2022 Q1	$299K	Sell	1,079 -804	-43%	-$222K	﹤0.01%	1047
2021 Q4	$411K	Hold	1,883	–	–	﹤0.01%	981
2021 Q3	$854K	Hold	1,883	–	–	﹤0.01%	876
2021 Q2	$1.11M	Buy	+1,883	New	+$996K	0.01%	792

Other funds holding VCNX

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Point72 Asset Management's VCNX Position: Q4 2024 in Review

Point72 Asset Management sold out of Vaccinex, Inc. Common Stock (VCNX) in Q4 2024, closing a stake of 166,000 shares — an estimated $564K sold.

Point72 Asset Management first reported a position in VCNX in Q2 2021 and held it in 7 quarters. The position peaked at $1.11M in Q2 2021. 1 fund tracked by Wall St. Rank holds VCNX as of Q4 2024.

Point72 Asset Management reported no remaining Vaccinex, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Point72 Asset Management sold 166,000 Vaccinex, Inc. Common Stock shares in Q4 2024, an estimated $564K.
Point72 Asset Management first reported a position in Vaccinex, Inc. Common Stock in Q2 2021 and held it in 7 quarters.
Point72 Asset Management's Vaccinex, Inc. Common Stock position peaked at $1.11M in Q2 2021.
1 fund tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q4 2024.

Based on Point72 Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.